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Abstract We examined the impact of physical activity
(PA) on surrogate markers of cardiovascular health in
adolescents. 52 healthy students (28 females, mean age
14.5 ± 0.7 years) were investigated. Microvascular endo-
thelial function was assessed by peripheral arterial to-
nometry to determine reactive hyperemic index (RHI).
Vagal activity was measured using 24 h analysis of heart
rate variability [root mean square of successive normal-to-
normal intervals (rMSSD)]. Exercise testing was per-
formed to determine peak oxygen uptake ( _VO2peak) and
maximum power output. PA was assessed by accelerome-
try. Linear regression models were performed and adjusted
for age, sex, skinfolds, and pubertal status. The cohort was
dichotomized into two equally sized activity groups (low
vs. high) based on the daily time spent in moderate-to-
vigorous PA (MVPA, 3,000–5,200 counts.min-1, model 1)
and vigorous PA (VPA, [5,200 counts.min-1, model 2).
MVPA was an independent predictor for rMSSD (b =
0.448, P = 0.010), and VPA was associated with maxi-
mum power output (b = 0.248, P = 0.016). In model 1,
the high MVPA group exhibited a higher vagal tone
(rMSSD 49.2 ± 13.6 vs. 38.1 ± 11.7 ms, P = 0.006) and
a lower systolic blood pressure (107.3 ± 9.9 vs.
112.9 ± 8.1 mmHg, P = 0.046). In model 2, the high
VPA group had higher maximum power output values
(3.9 ± 0.5 vs. 3.4 ± 0.5 W kg-1, P = 0.012). In both
models, no significant differences were observed for RHI
and _VO2peak. In conclusion, in healthy adolescents, PA was
associated with beneficial intensity-dependent effects on
vagal tone, systolic blood pressure, and exercise capacity,
but not on microvascular endothelial function.
Keywords Peripheral arterial tonometry  Heart rate
variability  Blood pressure  Fitness  Accelerometry
Introduction
Risk factors for cardiovascular disease (CVD) develop
early in life (Berenson et al. 1998) and tend to cluster in
adulthood. Physical activity (PA) plays a pivotal role in the
prevention of CVD and is inversely related with clustering
of CVD risk factors in children and adolescents (Andersen
et al. 2006). In adults, reduced exercise capacity, endo-
thelial dysfunction and diminished autonomic nervous
system activity are predictive for future cardiovascular
events and/or mortality (Myers et al. 2002; Rubinshtein
et al. 2011; Tsuji et al. 1994; Zulfiqar et al. 2010).
Alterations in cardiovascular health-related markers are
already present in healthy but inactive children and ado-
lescents when compared to their active peers (Hopkins
et al. 2009; Nagai and Moritani 2004; Trigona et al. 2010).
Regular PA favorably affects the cardiovascular system
and improves cardiorespiratory fitness (Anderssen et al.
2007), endothelial function (Clarkson et al. 1999), and
autonomic tone (Gutin et al. 2005; Nagai et al. 2004). In
this context, data on the nitric oxide-mediated vascular
endothelial function of the large arteries indicate positive
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associations with either habitual general PA (Abbott et al.
2002; Pahkala et al. 2011) or predominantly high intensity
PA (Hopkins et al. 2009, 2011). Stone et al. (2009)
investigated the relationships between PA and resting
microvascular function using iontophoresis combined with
laser Doppler perfusion imaging in pre-pubertal boys. No
association between PA levels and resting microvascular
endothelial function was observed. However, their study
included only healthy boys and since PA levels are known
to decline from childhood to adolescence, with girls being
consistently less active than boys (Nader et al. 2008), we
considered it appropriate to assess the potentially beneficial
effects of PA on microvascular endothelial function in a
more heterogeneous group of mixed sex adolescents. Fur-
thermore, the importance of PA intensity on most cardio-
vascular health related markers is less well understood.
Therefore, we simultaneously evaluated the impact of
different levels of PA intensity on exercise capacity,
microvascular endothelial function, and autonomic tone.
We hypothesized that in healthy adolescents, greater vol-
umes of at least moderate PA would be positively associ-
ated with enhanced microvascular endothelial function,
cardiorespiratory fitness and autonomic tone.
Materials and methods
Participants
A convenient sample of healthy adolescents of normal
body weight was recruited from an elementary school in
Olten, Switzerland. Exclusion criteria were diseases or
behaviors that potentially affect microvascular endothelial
function at an early age such as juvenile rheumatoid
arthritis or vascular diseases (Reynaud’s or Kawasaki’s
disease), hypertension (National High Blood Pressure
Education Program Working Group on High Blood Pressure
in Children and Adolescents 2004), obesity (Fernandez et al.
2004), diabetes, depression, smoking, and intake of vaso-
active medications. Written informed consent was obtained
from all participating subjects and parents/caregivers.
Ethical approval was obtained from the cantonal ethical
committee of Bern, Switzerland.
Experimental design
Consenting adolescents reported to the temporary labora-
tory set up at the school on one occasion to complete a
number of physiological examinations. The tests were
divided into two 1-h sessions. In the first session anthro-
pometry, vital signs and microvascular endothelial function
were measured after an overnight fast. Then, subjects had a
1-h break and all of them received a standardized snack
containing a chocolate milk drink and a granola bar before
they performed a maximal cardiopulmonary exercise test in
the second test session. Ambulatory 24-h electrocardiog-
raphy was recorded on the same day and objective mea-
sures of PA using accelerometry were obtained within
±7 days after the examination. All subjects completed the
same testing schedule between 8:00 and 11:00 a.m. to
avoid any influence of circadian pattern.
Anthropometric and hemodynamic measurements
and family history
All anthropometric measures were taken by trained staff
according to standard procedures. Body mass was mea-
sured with light clothing to the nearest 0.1 kg using a
digital-balanced scale and stature to the nearest 0.5 cm
using a wall-mounted stadiometer. Body mass index (BMI)
was calculated as body mass divided by stature squared
(kg m-2). Waist circumference was measured twice at the
midpoint between the lowest rib and the iliac crest using an
anthropometric tape. Skinfold thickness was measured in
triplicate on the right side of the body and to the nearest
0.2 mm with a Harpenden caliper. The sum of four sites
(triceps, biceps, subscapular and suprailicial) was calculated
and the average of three measurements was used for analysis.
Pubertal stage (Tanner 1–5) was assessed using a validated
self-assessment tool (Morris 1980). Girls were asked about
their current menstrual cycle phase at the time of testing.
Menstrual cycles were divided into follicular phase (day
1–14 of the menstrual cycle) and luteal phase (day 15–28 of
the menstrual cycle). Resting blood pressure was measured
three times at 2-min interval at the right arm with an ade-
quate sized cuff using an oscillometric device (Dinamap XL;
Criticon Inc., Tampa, FL, USA). The z transformed mean of
the three measurements based on age- and sex-specific
norms (National High Blood Pressure Education Program
Working Group on High Blood Pressure in Children and
Adolescents 2004) were used for analyses. A 12-lead resting
electrocardiograph (ECG) was performed to exclude those
with increased risk for exercise-induced arrhythmias such as
long QT-syndrome. We assessed familial CVD risk factors
using a self-administered questionnaire for both parents/
caregivers. The questionnaire covered the most relevant risk
factors for CVD, i.e. hypertension, diabetes, dyslipidemia,
smoking and premature cardiovascular death. Premature
cardiovascular mortality was defined as sudden death or
myocardial infarction occurring\55 years of age in men and
\65 years of age in women.
Assessment of microvascular endothelial function
Microvascular endothelial function was measured by
peripheral arterial tonometry (Endo-PAT2000, Itamar
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Medical Ltd., Israel) in a quiet, temperature controlled and
light dimmed room (22–24 C). Reproducibility and fea-
sibility of this device have recently been demonstrated in
healthy adolescents (Selamet Tierney et al. 2009). Testing
was performed after an overnight fast with subjects in
supine position with the hands at heart level and the fingers
hanging freely. Prior to testing, subjects rested for at least
5 min to achieve steady-state conditions. Pneumatic fin-
gertip probes were placed on both index fingers and pulse-
volume amplitudes were recorded. After a 5-min baseline
measurement, ischemia was induced by a cuff that was
inflated to at least 220 mmHg over the non-dominant upper
arm and maintained for 5 min. The cuff was then rapidly
deflated and bilateral pulse-volume amplitudes were
recorded for 5 min. The RHI was automatically calculated
by a computerized algorithm of the software program.
Assessment of PA
PA measurements were obtained using a uniaxial acceler-
ometer (MTI/CSA 7164, ActiGraph, Shalimar, FL, USA).
The monitor was attached at the right hip with a belt and
worn for eight consecutive days, except for water activities,
contact sports and sleeping. Data from the accelerometers
were downloaded and checked for spurious counts. The
accelerometer was programmed to record PA data (raw
activity counts and steps) every 5 s which were summed
for each 60 s for further analyses. Excessively high counts
(C20,000) were removed from the analysis (Masse et al.
2005). Sustained periods of C20 min of continuous zero
values were interpreted as being due to unworn acceler-
ometers and were removed. A minimum of 5 days
including one weekend day with C9 h of wearing time on
each day were required for inclusion in the data analysis.
Data are expressed based on validated cut-offs (Treuth
et al. 2004), as total daily PA (counts min-1), light PA
(100–2,999 counts min-1), MVPA (3,000–5,200 counts -
min-1) and VPA ([5,200 counts min-1). Daily sedentary
activity was evaluated using a threshold of B100 counts -
min-1 (Hopkins et al. 2012; Treuth et al. 2004). In order of
a 5-min bout to classify for MVPA or VPA, at least 4 min
had to meet or exceed the respective threshold. Bouts of
PA are expressed as the total number of daily bouts and the
average duration per bout (min). Activity data were ana-
lyzed between 07:00 a.m. and 11:00 p.m.
Assessment of cardiorespiratory fitness
Cardiopulmonary exercise testing was performed on an
electromagnetically braked cycle ergometer (Schiller 911
S, Schiller-Reomed AG, Dietikon, Switzerland) with
online gas analysis until exhaustion. A progressive incre-
mental cycle protocol with an initial load of 20 W and an
increase of 10 to 25 W each min was chosen to assure
subjects achieve their limit of tolerance within 10 ± 2 min.
Respiratory parameters were measured continuously in an
open circuit system (CS 200, Schiller-Reomed AG, Dietikon,
Switzerland). Heart rate and cardiac rhythm were continu-
ously analyzed using a 12-lead ECG. All subjects received
verbal encouragement to reach their maximal performance.
Clinical signs of exhaustion and further objective criteria that
were used to confirm peak oxygen uptake ( _VO2peak) had been
achieved: heart rate[90 % of predicted maximum heart rate
for age, or respiratory exchange ratio[1.10, or oxygen plateau
\2 mL kg-1 min-1 increase in _VO2 with increasing work
rate. The highest _VO2 averaged over 15 s during the test was
taken as _VO2peak.
Analysis of autonomic tone by heart rate variability
(HRV)
Ambulatory electrocardiography (AECG) was performed
for 24 h and time domain parameters of HRV were ana-
lyzed according to current recommendations (Task Force
1996). The monitor (Lifecard CF, Del Mar Reynolds
Medical Inc, Irvine, CA, USA) provides ECG data with
high accuracy (12-bit resolution) and a sampling frequency
of 1,024 Hz. The device and electrodes were attached to
the chest on a normal school day between 10:00 and 12:00
a.m. All ECG recordings were beat-by-beat analyzed and
interpreted using the Pathfinder Software (Spacelabs
Healthcare, Nuremberg, Germany) and manually re-eval-
uated by an experienced cardiologist (M.W.). Premature
atrial and ventricular contractions were classified according
to onset and QRS morphology. For HRV analysis, the
program eliminated 1 RR interval before, and 2 intervals
after each non-sinus beat. Four standard 24-h time domain
measures were calculated: the standard deviation of nor-
mal-to-normal intervals (SDNN), the HRV triangular
index, the standard deviation of the average normal-to-
normal interval (SDANN), and the square root of the mean
squared differences of successive normal-to-normal inter-
vals (rMSSD). In addition to the time domain analyses,
measures of the maximum, minimum and mean heart rate
over the 24-h recording were recorded.
Statistical analysis
Statistical analysis was performed using the STATA 11
statistical software package (STATA Corporation, College
Station, TX, USA). Distribution of the data was examined
using the Shapiro–Wilk test. Data are presented as
mean ± standard deviation or median (inter-quartile
range), depending on whether the data were normally
distributed or not. Anthropometric characteristics were
Eur J Appl Physiol (2013) 113:1213–1222 1215
123
analyzed using the Student’s t test or Mann–Whitney U
test, as indicated. The v2 test was used to compare base-
line categorical variables between the groups. Multiple
linear regression analysis was performed to assess the
influence of factors (MVPA, VPA, age, sex, skinfold and
pubertal status) on the prespecified outcome variables
(RHI, rMSSD, _VO2peak and maximum power output). We
then applied two different regression models with the
cohort dichotomized into two equally sized activity
groups (low vs. high) based either on the daily time spent
in MVPA (3,000–5,200 counts min-1, model 1) or VPA
([5,200 counts min-1, model 2). Differences in the out-
come variables within the dichotomized groups were
further analysed using linear regression modelling. A
P value \0.05 was considered to indicate statistical
significance.
Results
Figure 1 presents a flow chart of study recruitment and
inclusion. Of the 52 adolescents (28 females, mean age
14.5 ± 0.7 years), PA data of 7 boys did not meet the
inclusion criteria and these subjects were therefore exclu-
ded from the analysis, leaving 45 adolescents in analyzed
sample. The ActiGraph accelerometer was worn for a mean
of 7.46 ± 0.78 days. Baseline characteristics revealed tal-
ler stature, higher _VO2peak and lower skinfolds for boys
than girls. There were no significant differences in age,
pubertal status and familial CVD risk factors between boys
and girls (Table 1). Total PA for the study sample was
387.6 (118.5) counts min-1. The median daily time (inter-
quartile range) spent in sedentary activity, light PA, MVPA
and VPA for the study sample was 721.7 (82.5), 145.1
(45.9), 34.0 (14.4) and 9.5 (8.0) min day-1, respectively.
Only 16 % of the whole study population achieved the
recommendations of 60 min day-1 of MVPA. No differ-
ences were observed in PA levels between boys and girls.
Fifty-nine percent of subjects classified as low MVPA
were also classified as low VPA and 61 % of subjects
classified as high MVPA were also classified as high
VPA.
Impact of PA on surrogate markers of cardiovascular
health
In multiple linear regression analysis, MVPA was signifi-
cantly associated with vagal activity. VPA, sex and sum of
four skinfolds were independent predictors for maximum
power output. No significant associations were found
between PA measures, RHI and _VO2peak. Neither MVPA
nor VPA was a significant predictor for _VO2peak (Table 2).
Dichotomization according to MVPA (model 1)
and VPA (model 2)
In both models, dichotomized PA groups did not differ
with regard to sex, pubertal status and girls’ menstrual
cycle phases. In model 1, there was a trend of higher
volumes in total PA (counts min-1) and VPA (min day-1).
No differences were observed for light PA and sedentary
activity. Compared to the low MVPA group, the high
MVPA group performed significantly more C5 min bouts
of MVPA. The VPA groups (model 2) differed in the
amount of total PA, MVPA, VPA, and in the number and
average time per bout of vigorous intensity (Table 3).
Microvascular endothelial function (reactive hyperemic
index)
In both models, the RHI showed no significant differences
between the low and high PA group (Fig. 2).
Autonomic tone (heart rate variability)
In model 1, the high MVPA group exhibited a higher
overall sympathetic nervous system activity (SDNN,
P = 0.019), enhanced vagal activity (rMSSD; P = 0.006)
and a lower minimum heart rate (P = 0.009), compared to
the low MVPA group (Table 4). Regression analysis
Fig. 1 Flow chart of subject recruitment and study enrolment
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performed in model 2 resulted in no significant differences
between the low versus high VPA group in any HRV-
related parameters (Fig. 2).
Cardiorespiratory fitness
In model 1, no differences were observed in maximum
power output and _VO2peak (42.4 ± 10.2 vs. 45.7 ± 9.8
mL kg-1 min-1) between the low versus high MVPA
group. In comparison, in model 2, the high VPA group had
significantly higher maximum power output values (P =
0.012), but no differences existed for _VO2peak (46.5 ± 10.4
vs. 41.6 ± 9.3 mL kg-1 min-1, see Fig. 2).
Blood pressure
Lower systolic blood pressure values were observed in the
high MVPA compared to the low MVPA group, whether
expressed in absolute values (Fig. 2) nor age- and sex-adjus-
ted z scores (0.065 ± 0.77 vs. -0.531 ± 0.84, P = 0.017).
No significant differences in systolic blood pressure were
found between the VPA groups (model 2, Fig. 2).
Discussion
The key finding of our study was the intensity-dependent
effect of PA on surrogate markers of cardiovascular health. In
particular, high volumes of MVPA favorably affected vagal
activity and systolic blood pressure, whereas high volumes of
VPA contributed to an improvement in exercise capacity.
However, in healthy adolescents, neither MVPA nor VPA was
associated with microvascular endothelial function.
The lack of association between PA and microvascular
endothelial function as measured by peripheral arterial
tonometry (PAT) has not been described previously in this
age group using accelerometry-derived PA data. Some
issues related to the present findings need to be addressed.
First, several studies using the flow-mediated dilation
(FMD) technique to assess endothelial function of the
brachial artery observed positive associations with PA in
healthy children and adolescents (Abbott et al. 2002;
Hopkins et al. 2009, 2011; Pahkala et al. 2011). Both PAT
as a measure of microvascular endothelial function and the
FMD technique that represents macrovascular function are
to a large extent nitric oxide dependent (Nohria et al. 2006).
Table 1 Baseline characteristics of the study population
All (N = 52) Girls (N = 28) Boys (N = 24) P value
Age (years) 14.5 ± 0.7 14.5 ± 0.7 14.5 ± 0.7 0.862
Stature (m) 1.69 ± 0.1 1.66 ± 0.5 1.73 ± 0.1 \0.001
Body mass (kg) 57.7 (10.3) 55.6 (9.4) 60.4 (11.7) 0.144
Body mass index (kg m-2) 19.8 ± 2.4 20.3 ± 2.6 19.8 ± 2.5 0.506
Waist circumference (cm) 69.5 (8.1) 67.5 (7.5) 71.4 (6.4) 0.114
Sum of four skinfolds (mm) 39.7 (23.4) 48.0 (13.8) 33.5 (16.1) \0.001
Resting heart rate (bpm) 69.4 ± 10.6 71.0 ± 10.9 67.5 ± 10.1 0.238
Systolic blood pressure (mmHg) 110.0 ± 9.4 109.2 ± 7.0 111.4 ± 12.5 0.466
_VO2peak (mL kg
-1 min-1) 44.8 ± 10.1 39.9 ± 8.1 51.6 ± 7.5 \0.001
Power output (W kg-1) 3.8 ± 0.7 3.3 ± 0.4 4.2 ± 0.5 \0.001
Peak heart rate (bpm) 191.9 ± 7.4 190.5 ± 7.9 193.4 ± 6.9 0.167
Accelerometer wear time (days) 8.0 (1.0) 8.0 (1.0) 7.0 (1.0) 0.193
MVPA (min day-1) 33.5 ± 11.2 31.9 ± 10.0 36.2 ± 11.8 0.261
Tanner stage
2 1 (0.2 %) – 1 (0.4 %) 0.585
3 9 (18 %) 6 (21 %) 3 (13 %)
4 33 (63 %) 16 (57 %) 16 (67 %)
5 9 (18 %) 5 (18 %) 4 (17 %)
Familial CVD risk factors
Hypertension 7 (15 %) 4 (15 %) 3 (15 %) 0.971
Diabetes 2 (0.4 %) 1 (4 %) 1 (5 %) 0.849
Dyslipidemia 9 (20 %) 4 (15 %) 5 (25 %) 0.948
Smoking 6 (13 %) 3 (12 %) 5 (25 %) 0.482
Premature cardiovascular death 4 (9 %) 3 (12 %) 3 (15 %) 0.512
Data are presented as mean ± SD or median (inter-quartile range) or N (%). A P value \0.05 indicates statistical significance
bpm beats per minute, CVD cardiovascular disease, MVPA moderate-to-vigorous physical activity
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While previous studies with relatively small sample sizes
reported positive associations between the two methods
(Dhindsa et al. 2008; Nohria et al. 2006), recent data using sex-
and age-adjusted and multivariable-adjusted analyses on a
large population revealed no associations between PAT and
FMD (Hamburg et al. 2011). By direct comparison, inhibition
Table 2 Impact of physical activity on surrogate markers of cardiovascular health
Beta coefficient Standard error beta Standardized b P value
Reactive hyperemic index (R2 = 0.083)
MVPA -0.007 0.007 -0.199 0.296
VPA -0.004 0.009 -0.078 0.669
rMSSD (ms; R2 = 0.313)
MVPA 0.553 0.203 0.448 0.010
VPA 0.018 0.259 0.011 0.946
Sex -9.422 4.306 -0.335 0.035
Power output (W kg-1; R2 = 0.731)
Sex -0.525 0.120 -0.410 \0.001
Sum of four skinfolds -0.022 0.004 -0.560 \0.001
MVPA 0.001 0.006 0.011 0.914
VPA 0.018 0.007 0.248 0.016
Peak oxygen uptake (mL kg-1min-1; R2 = 0.749)
Sex -8.542 1.805 -0.427 \0.001
Sum of four skinfolds -0.362 0.064 -0.598 \0.001
MVPA 0.050 0.087 0.056 0.570
VPA 0.143 0.110 0.123 0.210
Multiple regression analysis adjusted for age, sex, sum of four skinfolds, pubertal status, MVPA and VPA. The variables age, sex, sum of four
skinfolds and pubertal status were only presented when statistical significant. Sex 1 = male, 2 = female. P \ 0.05 indicates statistical
significance
MVPA moderate-to-vigorous physical activity (min day-1), VPA vigorous physical activity (min day-1), rMSSD square root of the mean squared
differences of successive normal-to-normal intervals (ms)
Table 3 Descriptive characteristics of physical activity measurements dichotomized according to the daily time spent in moderate-to-vigorous
and vigorous physical activity
Model 1 Model 2
Moderate-to-vigorous physical activity Vigorous physical activity
Low (N = 22) High (N = 23) P value Low (N = 22) High (N = 23) P value
Female sex (N (%)) 15 (66 %) 13 (57 %) 0.542 15 (68 %) 13 (57 %) 0.542
Accelerometer wear time (days) 7.0 (1.0) 8.0 (1.0) 0.718 8.0 (1.0) 7.0 (1.0) 0.124
Total PA (counts min-1) 361.25 (146.8) 410.2 (110.1) 0.077 328.2 (129.1) 431.2 (60.2) \0.001
Light PA (min day-1) 152.1 ± 28.0 150.8 ± 35.0 0.886 143.4 ± 31.0 159.1 ± 30.4 0.094
MVPA (min day-1) 24.8 ± 6.8 41.9 ± 7.6 \0.001 28.9 ± 9.4 37.8 ± 11.1 0.005
VPA (min day-1) 8.1 (7.3) 11.2 (8.4) 0.080 5.4 (6.0) 13.2 (5.8) \0.001
Sedentary activity (minday-1) 702.9 (85.3) 735.8 (76.7) 0.266 739.9 (97.4) 715.5 (56.5) 0.401
Bouts of C5 min of MVPA
Total daily bouts (N) 1.88 (1.5) 3.40 (2.2) \0.001 1.90 (1.0) 2.40 (2.0) 0.062
Average time per bout (min) 8.0 (2.0) 8.5 (2.0) \0.001 7.6 (2.0) 7.6 (2.0) 0.524
Bouts of C5 min of VPA
Total daily bouts (N) 0.10 (0) 0.30 (1.0) 0.524 0 (0) 0.5 (0) \0.001
Average time per bout (min) 5.8 (10.0) 6.7 (10.0) 0.588 0 (8.0) 8.4 (4.0) 0.012
Data are presented as mean ± SD or median (inter-quartile range) or N (%). _VO2peak peak oxygen consumption. Data were analyzed using
Student’s t test or Mann–Whitney U test or v2 test. A P value \0.05 indicates statistical significance
MVPA moderate-to-vigorous physical activity, PA physical activity, VPA vigorous physical activity
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of endothelial nitric oxide synthase with intra-arterial infusion
of NG-nitro-L-arginine methyl ester (L-NAME) blunted the
reactive hyperemic response by only 46 ± 21 % using PAT
(Nohria et al. 2006) while an exclusively nitric oxide-medi-
ated vasodilation of the brachial artery has been observed
using FMD during distal wrist occlusion (Doshi et al. 2001).
This underlines the importance of different physiological
mechanisms contributing to different vascular responses
between measures of micro- versus macrocirculation
(Dhindsa et al. 2008), possibly contributing to the lack of
relationship in our study sample. Another explanation for the
lack of difference in the RHI between our groups could be the
Fig. 2 Comparison of reactive
hyperemic index, rMSSD,
power output and systolic blood
pressure between the low versus
high MVPA group (model 1)
and the low versus high VPA
group (model 2). Data are
mean ± SEM. rMSSD square
root of the mean squared
differences of successive
normal-to-normal intervals
Table 4 24-h ECG Holter monitoring and analysis of time domain heart rate variability parameters
Model 1 Model 2
Moderate-to-vigorous physical activity Vigorous physical activity
Low (N = 22) High (N = 23) P value Low (N = 22) High (N = 23) P value
Mean ECG wear time (h) 23.9 ± 1.1 23.5 ± 1.2 0.275 23.9 ± 1.1 23.6 ± 1.2 0.400
Mean heart rate (bpm) 82.5 ± 9.8 77.4 ± 9.9 0.092 80.2 ± 12.0 79.5 ± 8.1 0.829
Maximum heart rate (bpm) 170.7 ± 18.3 170.2 ± 17.6 0.921 172.0 ± 15.8 169.9 ± 20.3 0.382
Minimum heart rate (bpm) 54.7 ± 5.4 49.4 ± 7.3 0.009 53.3 ± 7.5 50.7 ± 6.2 0.203
rMSSD (ms) 38.1 ± 11.7 49.2 ± 13.6 0.006 40.7 ± 13.1 46.8 ± 14.1 0.345
SDNN (ms) 167.0 (31) 198.0 (76) 0.019 167.0 (42) 183.0 (66) 0.093
SDANN (ms) 154.0 (28) 180.0 (69) 0.026 156.0 (29) 166.0 (66) 0.113
HRV triangular index 49.0 (11) 50.0 (24) 0.235 49.0 (20) 50.0 (19) 0.580
Data are presented as mean ± SD or median (inter-quartile range). Data were analyzed using Student’s t test or Mann–Whitney U test. A P value
\0.05 indicates statistical significance
ECG electrocardiograph, bpm beats per minute, HRV heart rate variability, rMSSD square root of the mean squared differences of normal-to-
normal intervals, SDNN standard deviation of normal-to-normal intervals, SDANN standard deviation of the average normal-to-normal intervals
Eur J Appl Physiol (2013) 113:1213–1222 1219
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fact that our adolescents did not engage in a sufficient volume
of PA to induce favorable effects on the vascular endothelium
at the fingertips. Consistent with our findings, Stone et al.
(2009) reported no relationship between objective measures
of PA and resting microvascular endothelial function assessed
by iontophoresis and laser Doppler perfusion imaging in
healthy pre-pubertal boys, suggesting that adaptation in
endothelial function to PA levels may be detected in large
conduit arteries at an earlier age compared to small resistance
vessels. On the other hand, in our study, even small differences
in daily MVPA (17 min day-1) were positively related to
improved autonomic tone. The high MVPA group exhibited a
higher overall sympathetic nervous system activity, higher
vagal activity and a lower minimum heart rate. The associa-
tion of greater volumes of MVPA and higher vagal activity has
also been demonstrated with short term recordings of HRV in
a cross-sectional study in 304 healthy adolescents (Gutin et al.
2005). In accordance with our data, a 7-week high-intensity
intermittent interval training did not translate into improve-
ments in HRV parameters in healthy pre-pubertal children,
assuming that moderate rather than vigorous activities posi-
tively influence autonomic tone in children and adolescents
(Gamelin et al. 2009). While short-term recordings are per-
formed under laboratory conditions, we selected 24-h Holter
monitoring to better reflect circadian fluctuation and everyday
life activities (Task Force 1996).
We found a 5–6 mmHg difference in systolic blood
pressure between the high-volume and low-volume MVPA
group (model 1). Even such a small difference may have a
clinical impact, as elevated blood pressure values during
childhood are known to track into adulthood. In adults, it
has been assumed that a reduction of 5 mmHg in the sys-
tolic blood pressure distribution is likely to translate into a
reduced mortality risk from stroke and coronary heart
disease by 14 and 9 %, respectively (Whelton et al. 2002).
The study of Leary et al. (2008) showed that PA volume
rather than PA intensity is predominantly associated with
improved blood pressure profiles. Our data suggest that
also PA intensity is important, favoring MVPA over VPA.
In addition to the beneficial effects observed for MVPA,
greater volumes of VPA (model 2) were associated with
higher power output values following maximal cardiopul-
monary exercise testing. Anderssen et al. (2007), in a cross-
sectional study of 2,845 school age youths, found low
cardiorespiratory fitness strongly associated with clustering
of CVD risk factors, independently of age and sex. In
adults, reduced exercise capacity is associated with all-
cause mortality (Myers et al. 2002). In our study, sex and
the sum of four skinfolds were strongly influencing factors
for power output and _VO2peak. The lack of a relationship
between VPA volume and _VO2peak may partially be
explained by genetic predisposition.
The novelty of our study consisted of the simultaneous
assessment of a range of surrogate markers of cardiovas-
cular health. Consequently, we were able to differentiate
between the specific benefits of MVPA for vagal activity
and blood pressure, as well as VPA for fitness in our
population of healthy adolescents. Current PA guidelines
for school-youth recommend to perform 60 or more min-
utes of daily MVPA (Strong et al. 2005) and incorporating
vigorous intensity aerobic exercises at least three times per
week (World Health Organization 2010). In our study, only
16 % were able to reach C60 min day-1 of MVPA using a
threshold of 3,000–5,200 counts min-1 (Treuth et al.
2004). However, even a difference of approximately
17 min of daily MVPA resulted in enhanced vagal activity
and lower systolic blood pressure between the low versus
high activity groups. In addition, higher volumes of daily
VPA were associated with an improved exercise capacity.
The present study has certain limitations. First, because
of the cross-sectional study design, we cannot establish
causal relationships between measures of PA and the
selected outcome variables. The lack of difference in PA
levels between boys and girls in our study contradicts
previous findings (Nader et al. 2008). We believe that this
observation is due to selection bias, because we recruited
voluntary subjects who were likely to be more active than
the non-volunteering peers. Second, we have recently
shown that microvascular endothelial function increases
with pubertal maturation in healthy children and adoles-
cents (Radtke et al. 2012). Pubertal status may introduce a
confounding factor with regard to detecting associations
between PA and microvascular endothelial function, as
vascular beds in the fingertip in this age group may be
differently matured. However, no differences with respect
to the mean age and pubertal status existed neither between
the groups of model 1 nor model 2. Third, accelerometry
measurements were performed during June and October. It
has been shown that PA levels, in particular vigorous PA,
change with seasonal variation and can potentially impact
on microvascular function (Hopkins et al. 2011). In addi-
tion, the increased production of estrogen and progesterone
during the menstrual cycle in females is known to affect the
vasodilatory response of conduit arteries. We did not
schedule testing during a particular cycle phase. However,
the distribution of girls’ menstrual cycle phases (luteal and
follicular phase) was well balanced between girls in model
1 and model 2.
Conclusion
In conclusion, our results support current PA guidelines
that both MVPA and VPA are important for cardiovascular
1220 Eur J Appl Physiol (2013) 113:1213–1222
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health. VPA contributed to an improved exercise capacity
and MVPA was associated with an enhanced vagal tone
and a lower systolic blood pressure. However, in healthy
adolescents, higher PA volumes did not translate into an
improvement in microvascular endothelial function.
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